207 related articles for article (PubMed ID: 7815516)
1. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses.
Feuer G; Stewart SA; Baird SM; Lee F; Feuer R; Chen IS
J Virol; 1995 Feb; 69(2):1328-33. PubMed ID: 7815516
[TBL] [Abstract][Full Text] [Related]
2. HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice.
Stewart SA; Feuer G; Jewett A; Lee FV; Bonavida B; Chen IS
Virology; 1996 Dec; 226(2):167-75. PubMed ID: 8955035
[TBL] [Abstract][Full Text] [Related]
3. Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice.
Liu Y; Dole K; Stanley JR; Richard V; Rosol TJ; Ratner L; Lairmore M; Feuer G
Leuk Res; 2002 Jun; 26(6):561-7. PubMed ID: 12007504
[TBL] [Abstract][Full Text] [Related]
4. Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice.
Feuer G; Zack JA; Harrington WJ; Valderama R; Rosenblatt JD; Wachsman W; Baird SM; Chen IS
Blood; 1993 Aug; 82(3):722-31. PubMed ID: 8338942
[TBL] [Abstract][Full Text] [Related]
5. Enhanced engraftment of HTLV-I-infected human T cells in severe combined immunodeficiency mice by anti-asialo GM-1 antibody treatment.
Ishihara S; Okayama A; Nagatomo Y; Murai K; Yamashita R; Okamoto M; Shima T; Sasaki T; Mueller N; Tachibana N; Tsubouchi H
Microbiol Immunol; 1996; 40(1):39-44. PubMed ID: 8871527
[TBL] [Abstract][Full Text] [Related]
6. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell lymphotropic virus type-I infection in the severe combined immunodeficiency mouse.
Furlan R; Salazar-Grueso EF; Martino G; Roos RP; Brambilla E; Castellano M; Cao J; Lillo F; Terreni MR; Bacellar H; Dorigatti F; Grimaldi LM
J Med Virol; 1996 Jun; 49(2):77-82. PubMed ID: 8991939
[TBL] [Abstract][Full Text] [Related]
8. Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
Richard V; Lairmore MD; Green PL; Feuer G; Erbe RS; Albrecht B; D'Souza C; Keller ET; Dai J; Rosol TJ
Am J Pathol; 2001 Jun; 158(6):2219-28. PubMed ID: 11395400
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenicity of human T-cell leukemia virus type I-infected cell lines in severe combined immunodeficient mice and characterization of the cells proliferating in vivo.
Imada K; Takaori-Kondo A; Akagi T; Shimotohno K; Sugamura K; Hattori T; Yamabe H; Okuma M; Uchiyama T
Blood; 1995 Sep; 86(6):2350-7. PubMed ID: 7662981
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
Mori N; Matsuda T; Tadano M; Kinjo T; Yamada Y; Tsukasaki K; Ikeda S; Yamasaki Y; Tanaka Y; Ohta T; Iwamasa T; Tomonaga M; Yamamoto N
J Virol; 2004 May; 78(9):4582-90. PubMed ID: 15078940
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of in vivo cell proliferation of ATL using SCID mice].
Imada K; Takaori-Kondo A; Uchiyama T
Rinsho Ketsueki; 1995 Jun; 36(6):573-7. PubMed ID: 7643453
[TBL] [Abstract][Full Text] [Related]
12. Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
Haneji K; Matsuda T; Tomita M; Kawakami H; Ohshiro K; Uchihara JN; Masuda M; Takasu N; Tanaka Y; Ohta T; Mori N
Nutr Cancer; 2005; 52(2):189-201. PubMed ID: 16201850
[TBL] [Abstract][Full Text] [Related]
13. ATL and HTLV-I: in vivo cell growth of ATL cells.
Uchiyama T
J Clin Immunol; 1996 Nov; 16(6):305-14. PubMed ID: 8946274
[TBL] [Abstract][Full Text] [Related]
14. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus.
Sugamura K; Fujii M; Kannagi M; Sakitani M; Takeuchi M; Hinuma Y
Int J Cancer; 1984 Aug; 34(2):221-8. PubMed ID: 6088403
[TBL] [Abstract][Full Text] [Related]
15. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
16. Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone.
Kohart NA; Elshafae SM; Supsahvad W; Alasonyalilar-Demirer A; Panfil AR; Xiang J; Dirksen WP; Veis DJ; Green PL; Weilbaecher KN; Rosol TJ
J Bone Oncol; 2019 Dec; 19():100257. PubMed ID: 31871882
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
Ishikawa C; Matsuda T; Okudaira T; Tomita M; Kawakami H; Tanaka Y; Masuda M; Ohshiro K; Ohta T; Mori N
Br J Haematol; 2007 Feb; 136(3):424-32. PubMed ID: 17233845
[TBL] [Abstract][Full Text] [Related]
18. Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines.
Fukudome K; Furuse M; Fukuhara N; Orita S; Imai T; Takagi S; Nagira M; Hinuma Y; Yoshie O
Int J Cancer; 1992 Sep; 52(3):418-27. PubMed ID: 1356935
[TBL] [Abstract][Full Text] [Related]
19. Association of HTLV-I with autoimmune thyroiditis in patients with adult T-cell leukaemia (ATL) and in HTLV-I carriers.
Akamine H; Takasu N; Komiya I; Ishikawa K; Shinjyo T; Nakachi K; Masuda M
Clin Endocrinol (Oxf); 1996 Oct; 45(4):461-6. PubMed ID: 8959086
[TBL] [Abstract][Full Text] [Related]
20. In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia.
Ohsugi T; Horie R; Kumasaka T; Ishida A; Ishida T; Yamaguchi K; Watanabe T; Umezawa K; Urano T
Carcinogenesis; 2005 Aug; 26(8):1382-8. PubMed ID: 15831528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
